An Electronic Health Record Compatible Model to Predict Personalized Treatment Effects from the Diabetes Prevention Program: A Cross-Evidence Synthesis Approach Using Clinical Trial and Real World Data
View ORCID ProfileDavid M Kent, Jason Nelson, Anastassios Pittas, Francis Colangelo, Carolyn Koenig, David van Klaveren, Elizabeth Ciemins, John Cuddeback
doi: https://doi.org/10.1101/2021.01.06.21249334
David M Kent
1Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center, Boston, MA
Jason Nelson
1Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center, Boston, MA
Anastassios Pittas
2Division of Endocrinology, Tufts Medical Center, Boston, MA
Francis Colangelo
3Allegheny Health Network, Pittsburgh, PA
Carolyn Koenig
4Mercy Health, St. Louis, MO
David van Klaveren
1Predictive Analytics and Comparative Effectiveness Center, Tufts Medical Center, Boston, MA
5Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands
Elizabeth Ciemins
6AMGA (American Medical Group Association), Alexandria, VA
John Cuddeback
6AMGA (American Medical Group Association), Alexandria, VA

Data Availability
The data that support the findings of this study are available from OptumLabs but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of OptumLabs.
Posted January 08, 2021.
An Electronic Health Record Compatible Model to Predict Personalized Treatment Effects from the Diabetes Prevention Program: A Cross-Evidence Synthesis Approach Using Clinical Trial and Real World Data
David M Kent, Jason Nelson, Anastassios Pittas, Francis Colangelo, Carolyn Koenig, David van Klaveren, Elizabeth Ciemins, John Cuddeback
medRxiv 2021.01.06.21249334; doi: https://doi.org/10.1101/2021.01.06.21249334
An Electronic Health Record Compatible Model to Predict Personalized Treatment Effects from the Diabetes Prevention Program: A Cross-Evidence Synthesis Approach Using Clinical Trial and Real World Data
David M Kent, Jason Nelson, Anastassios Pittas, Francis Colangelo, Carolyn Koenig, David van Klaveren, Elizabeth Ciemins, John Cuddeback
medRxiv 2021.01.06.21249334; doi: https://doi.org/10.1101/2021.01.06.21249334
Subject Areas
- Addiction Medicine (76)
- Allergy and Immunology (202)
- Anesthesia (55)
- Cardiovascular Medicine (495)
- Dermatology (57)
- Emergency Medicine (170)
- Epidemiology (5756)
- Gastroenterology (222)
- Geriatric Medicine (89)
- Health Economics (233)
- Health Informatics (777)
- Health Policy (400)
- Hematology (105)
- HIV/AIDS (188)
- Medical Education (119)
- Medical Ethics (29)
- Nephrology (94)
- Neurology (859)
- Nursing (46)
- Nutrition (143)
- Oncology (521)
- Ophthalmology (168)
- Orthopedics (44)
- Otolaryngology (107)
- Pain Medicine (48)
- Palliative Medicine (22)
- Pathology (150)
- Pediatrics (258)
- Primary Care Research (116)
- Public and Global Health (2266)
- Radiology and Imaging (380)
- Respiratory Medicine (314)
- Rheumatology (110)
- Sports Medicine (83)
- Surgery (118)
- Toxicology (25)
- Transplantation (35)
- Urology (42)